Orbita, Marites .

HRN: 16-58-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2024
CEFUROXIME 1.5GM (VIAL)
12/15/2024
12/16/2024
IV
1.5gms IV
Now
STAT CS
Waiting Final Action 
12/15/2024
CEFUROXIME 1.5GM (VIAL)
12/15/2024
12/16/2024
IV
1.5g
Q8hrs
S/P LSTCS
Waiting Final Action 
12/15/2024
CEFUROXIME 500MG (TAB)
12/16/2024
12/23/2024
ORAL
500mg
BID
S/P LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: